Literature DB >> 1685304

Cymelarsan in the treatment of buffaloes naturally infected with Trypanosoma evansi in south China.

Z R Lun1, Z P Min, D Huang, J X Liang, X F Yang, Y T Huang.   

Abstract

Forty buffaloes naturally infected with Trypanosoma evansi in the South of China were treated with a single dose of a new arsenical. Cymelarsan (Mel Cy) at 0.25 mg/kg to 3.0 mg/kg by intramuscular injection. All animals were cured, with the exception of two out of four animals treated with 0.25 mg/kg Mel Cy which relapsed two months after drug administration. Two out of eight buffaloes in control groups treated with a single dose of diminazene aceturate (Berenil), 3.5 mg/kg, relapsed two months after treatment. All cured animals showed no trypanosomes in their blood when tested within one to three years after administration. A scleroma about 2 to 3.5 cm in diameter was found at the site of injection at the dose of 1.5 mg/kg Mel Cy in three of eight animals. At a dose of 3 mg/kg, Mel Cy induced obvious necrosis of the tissue at the site of injection. The results of field application proved that Mel Cy is a very active trypanocidal drug against T. evansi.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1685304     DOI: 10.1016/0001-706x(91)90042-i

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  6 in total

1.  Contribution of dithiol ligands to in vitro and in vivo trypanocidal activities of dithiaarsanes and investigation of ligand exchange in an aqueous solution.

Authors:  P M Loiseau; P Lubert; J G Wolf
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

2.  Properties of melarsamine hydrochloride (Cymelarsan) in aqueous solution.

Authors:  B J Berger; A H Fairlamb
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

3.  Efficacy of diminazene diaceturate and isometamidium chloride hydrochloride for the treatment of Trypanosoma evansi in mice model.

Authors:  Weldegebrial G Aregawi; Fikadu Gutema; Juhar Tesfaye; Abel Sorsa; Brehanu Megersa; Philimon Teshome; Getahun E Agga; Hagos Ashenafi
Journal:  J Parasit Dis       Date:  2020-10-12

Review 4.  Trypanosoma evansi and surra: a review and perspectives on transmission, epidemiology and control, impact, and zoonotic aspects.

Authors:  Marc Desquesnes; Alan Dargantes; De-Hua Lai; Zhao-Rong Lun; Philippe Holzmuller; Sathaporn Jittapalapong
Journal:  Biomed Res Int       Date:  2013-09-18       Impact factor: 3.411

5.  Systematic review and meta-analysis on the global distribution, host range, and prevalence of Trypanosoma evansi.

Authors:  Weldegebrial G Aregawi; Getahun E Agga; Reta D Abdi; Philippe Büscher
Journal:  Parasit Vectors       Date:  2019-01-31       Impact factor: 3.876

6.  The Indirect ELISA Trypanosoma evansi in Equids: Optimisation and Application to a Serological Survey including Racing Horses, in Thailand.

Authors:  Margot Camoin; Arthur Kocher; Piangjai Chalermwong; Sarawut Yangtarra; Ketsarin Kamyingkird; Sathaporn Jittapalapong; Marc Desquesnes
Journal:  Biomed Res Int       Date:  2019-12-05       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.